• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型冠状病毒2型疫苗接种消除了原始抗原罪。

SARS-CoV-2 vaccination washes away original antigenic sin.

作者信息

Pillai Shiv

机构信息

Ragon Institute of MGH, MIT and Harvard, Cambridge, MA, 02139, USA.

出版信息

Trends Immunol. 2022 Apr;43(4):271-273. doi: 10.1016/j.it.2022.02.009. Epub 2022 Feb 28.

DOI:10.1016/j.it.2022.02.009
PMID:35272935
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8882427/
Abstract

According to Röltgen and colleagues vaccination generates antibody breadth, whereas SARS-CoV-2 infection does not. Vaccination results in germinal center B cell responses and generates immunological breadth, with antibodies that bind viral variants. COVID-19 from SARS-CoV-2 infection does not induce germinal centers; it sustains immune imprinting, also known as 'original antigenic sin', and this results in limited immunological breadth.

摘要

根据勒尔特根及其同事的研究,接种疫苗可产生抗体广度,而感染新冠病毒则不会。接种疫苗会引发生发中心B细胞反应并产生免疫广度,所产生的抗体可结合病毒变体。新冠病毒感染所致的新冠肺炎不会诱导生发中心形成;它会维持免疫印记,即所谓的“原始抗原罪”,这会导致免疫广度有限。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ee5/8882427/231ab80ae4dd/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ee5/8882427/231ab80ae4dd/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ee5/8882427/231ab80ae4dd/gr1_lrg.jpg

相似文献

1
SARS-CoV-2 vaccination washes away original antigenic sin.新型冠状病毒2型疫苗接种消除了原始抗原罪。
Trends Immunol. 2022 Apr;43(4):271-273. doi: 10.1016/j.it.2022.02.009. Epub 2022 Feb 28.
2
SARS-CoV-2 vaccination in the context of original antigenic sin.SARS-CoV-2 疫苗接种与原始抗原性错误。
Hum Vaccin Immunother. 2022 Dec 31;18(1):1949953. doi: 10.1080/21645515.2021.1949953. Epub 2021 Jul 9.
3
Is 'original antigenic sin' complicating indian vaccination drive against Covid-19?“原始抗原性失误”是否使印度的新冠疫苗接种行动复杂化?
Hum Vaccin Immunother. 2021 Oct 3;17(10):3314-3315. doi: 10.1080/21645515.2021.1945904. Epub 2021 Jun 29.
4
Original antigen sin and COVID-19: implications for seasonal vaccination.原始抗原决定簇与 COVID-19:对季节性疫苗接种的影响。
Expert Opin Biol Ther. 2022 Nov;22(11):1353-1358. doi: 10.1080/14712598.2022.2137402. Epub 2022 Oct 18.
5
Comprehensive characterization of the antibody responses to SARS-CoV-2 Spike protein finds additional vaccine-induced epitopes beyond those for mild infection.全面描述了针对 SARS-CoV-2 刺突蛋白的抗体反应,发现了除轻度感染诱导的表位之外的其他疫苗诱导的表位。
Elife. 2022 Jan 24;11:e73490. doi: 10.7554/eLife.73490.
6
Getting to the (germinal) center of humoral immune responses to SARS-CoV-2.深入探究体液免疫应答 SARS-CoV-2 的(生发)中心。
Cell. 2022 Mar 17;185(6):945-948. doi: 10.1016/j.cell.2022.02.018.
7
SARS-CoV-2 Spike Protein Vaccine-Induced Immune Imprinting Reduces Nucleocapsid Protein Antibody Response in SARS-CoV-2 Infection.SARS-CoV-2 刺突蛋白疫苗诱导的免疫印迹降低了 SARS-CoV-2 感染中的核衣壳蛋白抗体反应。
J Immunol Res. 2022 Jul 29;2022:8287087. doi: 10.1155/2022/8287087. eCollection 2022.
8
Previous Infection Combined with Vaccination Produces Neutralizing Antibodies with Potency against SARS-CoV-2 Variants.既往感染与疫苗接种产生针对 SARS-CoV-2 变异株的中和抗体效力。
mBio. 2021 Dec 21;12(6):e0265621. doi: 10.1128/mBio.02656-21. Epub 2021 Dec 7.
9
Original Antigenic Sin: the Downside of Immunological Memory and Implications for COVID-19.原始抗原性失误:免疫记忆的负面影响及对 COVID-19 的启示。
mSphere. 2021 Mar 10;6(2):e00056-21. doi: 10.1128/mSphere.00056-21.
10
"Original antigenic sin": A potential threat beyond the development of booster vaccination against novel SARS-CoV-2 variants.“原始抗原罪”:针对新型SARS-CoV-2变体加强疫苗接种之外的潜在威胁。
Infect Control Hosp Epidemiol. 2022 Aug;43(8):1091-1092. doi: 10.1017/ice.2021.199. Epub 2021 May 3.

引用本文的文献

1
Back to the Future: Immune Protection or Enhancement of Future Coronaviruses.回到未来:对未来冠状病毒的免疫保护或增强
Microorganisms. 2024 Mar 19;12(3):617. doi: 10.3390/microorganisms12030617.
2
Use of immunology in news and YouTube videos in the context of COVID-19: politicisation and information bubbles.新冠疫情背景下新闻和YouTube视频中免疫学的运用:政治化与信息泡沫
Front Public Health. 2024 Feb 7;12:1327704. doi: 10.3389/fpubh.2024.1327704. eCollection 2024.
3
Immune imprinting and next-generation coronavirus vaccines.免疫印记与下一代冠状病毒疫苗。

本文引用的文献

1
Immune imprinting, breadth of variant recognition, and germinal center response in human SARS-CoV-2 infection and vaccination.人类 SARS-CoV-2 感染和接种疫苗中的免疫印迹、变体识别广度和生发中心反应。
Cell. 2022 Mar 17;185(6):1025-1040.e14. doi: 10.1016/j.cell.2022.01.018. Epub 2022 Jan 25.
2
SARS-CoV-2 mRNA vaccines induce persistent human germinal centre responses.SARS-CoV-2 mRNA 疫苗可诱导持久的人体生发中心反应。
Nature. 2021 Aug;596(7870):109-113. doi: 10.1038/s41586-021-03738-2. Epub 2021 Jun 28.
3
Loss of Bcl-6-Expressing T Follicular Helper Cells and Germinal Centers in COVID-19.
Nat Microbiol. 2023 Nov;8(11):1971-1985. doi: 10.1038/s41564-023-01505-9. Epub 2023 Nov 6.
4
Discovery and characterization of potent pan-variant SARS-CoV-2 neutralizing antibodies from individuals with Omicron breakthrough infection.从奥密克戎突破性感染个体中发现并鉴定出针对多种变异株的强效 SARS-CoV-2 中和抗体。
Nat Commun. 2023 Jun 15;14(1):3537. doi: 10.1038/s41467-023-39267-x.
5
Beta-containing bivalent SARS-CoV-2 protein vaccine elicits durable broad neutralization in macaques and protection in hamsters.含β的二价SARS-CoV-2蛋白疫苗在猕猴中引发持久的广泛中和作用,并在仓鼠中提供保护。
Commun Med (Lond). 2023 May 26;3(1):75. doi: 10.1038/s43856-023-00302-z.
6
Differential abundance of IgG antibodies against the spike protein of SARS-CoV-2 and seasonal coronaviruses in patients with fatal COVID-19.死于 COVID-19 的患者体内针对 SARS-CoV-2 刺突蛋白和季节性冠状病毒的 IgG 抗体的丰度差异。
Virol J. 2023 May 3;20(1):85. doi: 10.1186/s12985-023-02050-x.
7
Humoral Immunogenicity of mRNA Booster Vaccination after Heterologous CoronaVac-ChAdOx1 nCoV-19 or Homologous ChAdOx1 nCoV-19 Vaccination in Patients with Autoimmune Rheumatic Diseases: A Preliminary Report.自身免疫性风湿病患者在异源 CoronaVac-ChAdOx1 nCoV-19 或同源 ChAdOx1 nCoV-19 疫苗接种后 mRNA 加强疫苗接种的体液免疫原性:初步报告
Vaccines (Basel). 2023 Feb 24;11(3):537. doi: 10.3390/vaccines11030537.
8
The changing health impact of vaccines in the COVID-19 pandemic: A modeling study.在 COVID-19 大流行中,疫苗对健康影响的变化:一项建模研究。
Cell Rep. 2023 Apr 25;42(4):112308. doi: 10.1016/j.celrep.2023.112308. Epub 2023 Mar 15.
9
Editorial: Adaptive immunity to respiratory pathogens.社论:对呼吸道病原体的适应性免疫
Front Immunol. 2023 Mar 6;14:1174178. doi: 10.3389/fimmu.2023.1174178. eCollection 2023.
10
The protection quest is a primary key to sharing the neutralizing antibody response to cover against all emerging VOCs based on BIV1-CovIran studies.基于BIV1-CovIran研究,寻求保护是共享中和抗体反应以抵御所有新出现的变异株的关键。
Heliyon. 2023 Mar;9(3):e14108. doi: 10.1016/j.heliyon.2023.e14108. Epub 2023 Feb 26.
新冠病毒(COVID-19)中 Bcl-6 表达的滤泡辅助性 T 细胞和生发中心的缺失。
Cell. 2020 Oct 1;183(1):143-157.e13. doi: 10.1016/j.cell.2020.08.025. Epub 2020 Aug 19.
4
Visualization of early events in mRNA vaccine delivery in non-human primates via PET-CT and near-infrared imaging.通过 PET-CT 和近红外成像技术可视化非人灵长类动物 mRNA 疫苗传递的早期事件。
Nat Biomed Eng. 2019 May;3(5):371-380. doi: 10.1038/s41551-019-0378-3. Epub 2019 Apr 1.
5
Predetermination by infection and by vaccination of antibody response to influenza virus vaccines.感染和接种流感病毒疫苗对抗体反应的预先决定作用。
J Exp Med. 1957 Dec 1;106(6):835-50. doi: 10.1084/jem.106.6.835.